Mostra el registre d'ítem simple
Nanoparticles of esterified polymalic acid for controlled anticancer drug release
dc.contributor.author | Lanz Landazuri, Alberto |
dc.contributor.author | Martínez de Ilarduya Sáez de Asteasu, Domingo Antxon |
dc.contributor.author | Portilla Arias, Jose Antonio |
dc.contributor.author | García Álvarez, Montserrat |
dc.contributor.author | Holler, Eggehard |
dc.contributor.author | Ljubimova, Julia |
dc.contributor.author | Muñoz Guerra, Sebastián |
dc.contributor.other | Universitat Politècnica de Catalunya. Departament d'Enginyeria Química |
dc.date.accessioned | 2014-09-17T08:24:02Z |
dc.date.created | 2014-09-01 |
dc.date.issued | 2014-09-01 |
dc.identifier.citation | Lanz, A. [et al.]. Nanoparticles of esterified polymalic acid for controlled anticancer drug release. "Macromolecular bioscience", 01 Setembre 2014, vol. 14, núm. 9, p. 1325-1336. |
dc.identifier.issn | 1616-5187 |
dc.identifier.uri | http://hdl.handle.net/2117/24073 |
dc.description.abstract | Esterification of microbial poly(malic acid) is performed with either ethanol or 1-butanol to obtain polymalate conjugates capable to form nanoparticles (100–350 nm). Degradation under physiological conditions takes place with release of malic acid and the corresponding alcohol as unique degradation products. The anticancer drugs Temozolomide and Doxorubicin are encapsulated in nanoparticles with efficiency of 17 and 37%, respectively. In vitro drug release assays show that Temozolomide is almost completely discharged in a few hours whereas Doxorubicin is steadily released along several days. Drug-loaded nano-particles show remarkable effectiveness against cancer cells. Partially ethylated poly(malic acid) nano-particles are those showing the highest cellular uptake. |
dc.format.extent | 12 p. |
dc.language.iso | eng |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 Spain |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/es/ |
dc.subject | Àrees temàtiques de la UPC::Enginyeria química |
dc.subject.lcsh | Nanoparticles--Therapeutic use |
dc.subject.lcsh | Antineoplastic agents |
dc.subject.other | biodegradable drug delivery systems |
dc.subject.other | poly(malic acid) |
dc.subject.other | poly(malic acid) nanoparticles |
dc.title | Nanoparticles of esterified polymalic acid for controlled anticancer drug release |
dc.type | Article |
dc.subject.lemac | Nanopartícules -- Ús terapèutic |
dc.subject.lemac | Medicaments antineoplàstics |
dc.contributor.group | Universitat Politècnica de Catalunya. POL - Polímers Industrials Avançats i Biopolímers Tecnològics |
dc.identifier.doi | 10.1002/mabi.201400124 |
dc.description.peerreviewed | Peer Reviewed |
dc.relation.publisherversion | http://onlinelibrary.wiley.com/doi/10.1002/mabi.201400124/abstract |
dc.rights.access | Restricted access - publisher's policy |
local.identifier.drac | 15143365 |
dc.description.version | Postprint (published version) |
dc.date.lift | 10000-01-01 |
local.citation.author | Lanz, A.; Martinez de Ilarduya, A.; Portilla-Arias, J.; Garcia, M.; Holler, E.; Ljubimova, J.; Muñoz, S. |
local.citation.publicationName | Macromolecular bioscience |
local.citation.volume | 14 |
local.citation.number | 9 |
local.citation.startingPage | 1325 |
local.citation.endingPage | 1336 |
Fitxers d'aquest items
Aquest ítem apareix a les col·leccions següents
-
Articles de revista [114]
-
Articles de revista [2.226]